Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
PDGFRβ signaling restrains myocyte function to limit the regenerative capacity of skeletal muscle
Siwen Xue, Abigail M. Benvie, Jamie E. Blum, Benjamin D. Cosgrove, Anna E. Thalacker-Mercer, Daniel C. Berry
Siwen Xue, Abigail M. Benvie, Jamie E. Blum, Benjamin D. Cosgrove, Anna E. Thalacker-Mercer, Daniel C. Berry
View: Text | PDF
Research Article Development Muscle biology

PDGFRβ signaling restrains myocyte function to limit the regenerative capacity of skeletal muscle

  • Text
  • PDF
Abstract

Muscle cell fusion is critical for the formation and maintenance of multinucleated myotubes during skeletal muscle development and regeneration. However, the molecular mechanisms directing cell-cell fusion are not fully understood. Here, we identified platelet-derived growth factor receptor β (PDGFRβ) signaling as a key modulator of myocyte function in adult muscle cells. Our findings demonstrated that genetic deletion of Pdgfrb enhanced muscle regeneration and increased myofiber size, whereas Pdgfrb activation impaired muscle repair. Inhibition of PDGFRβ activity promoted myonuclear accretion in both mouse and human myotubes, whereas PDGFRβ activation stalled myotube development by preventing cell spreading to limit fusion potential. Furthermore, PDGFRβ activity cooperated with TGF-β signaling to regulate myocyte size and fusion. Mechanistically, PDGFRβ signaling required STAT1 activation, and blocking STAT1 phosphorylation enhanced myofiber repair and size during regeneration. Collectively, PDGFRβ signaling acts as a regenerative checkpoint and represents a potential clinical target to improve skeletal muscle repair.

Authors

Siwen Xue, Abigail M. Benvie, Jamie E. Blum, Benjamin D. Cosgrove, Anna E. Thalacker-Mercer, Daniel C. Berry

×

Figure 1

PDGFRβ is induced and activated in stimulated muscle progenitor cells.

Options: View larger image (or click on image) Download as PowerPoint
PDGFRβ is induced and activated in stimulated muscle progenitor cells.
(...
(A) Experimental design: Pax7tdTomato male mice received TMX at P60 and were left uninjured or injured with 1.2% BaCl2. TA muscles were collected, dissociated, and Pax7tdTomato-positive and -negative cells were isolated by FACS. Panel A was created using BioRender. (B) qPCR analysis of Pax7 and Pdgfrb in quiescent Pax7tdTomato-positive and -negative cells (n = 4 mice/group). (C) Pdgfrb mRNA levels in Pax7tdTomato cells under quiescence or at 3 d.p.i. (n = 3 mice/group). (D) Flow cytometric histograms showing PDGFRβ surface expression on quiescent and injured Pax7tdTomato cells. (E) Temporal Pdgfrb and myogenin mRNA expression during C2C12 differentiation (n = 4 independent cultures). (F) Immunoblot analysis of total and p-PDGFRβ levels during primary myogenic differentiation. (G) Immunoblot showing PDGFRβ and STAT1 phosphorylation in myocytes treated with vehicle or PDGF-BB (15 ng/mL, 15 min). Data represent the mean ± SEM. Statistical significance was determined using an unpaired, 2-tailed Student’s t test (B, C, and E). Rel., relative.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts